Search Results 51-60 of 16252 for monoclonal antibody
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.
A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response ...
Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13 · Overview · Participation eligibility.
Monoclonal antibodies, such as rituximab, may find cancer cells and help kill them. Radioactive substances linked to monoclonal antibodies can bind to cancer ...
Monoclonal antibodies, such as anti-endoglin monoclonal antibody TRC105 and bevacizumab, may find tumor cells and help kill them. Giving anti-endoglin ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... At least 6 weeks since prior monoclonal antibody therapy; At least 7 ...
Combining more than one chemotherapy drug with monoclonal antibody therapy and giving them after surgery may kill any remaining tumor cells. It was not ...
The Antibody Hybridoma Core at Mayo Clinic produces monoclonal antibodies using immunized mice housed in a pathogen-free colony.
Monoclonal antibodies, such as ipilimumab and nivolumab, may interfere with the ability of cancer cells to grow and spread. Brentuximab vedotin is a combining ...
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.